Nodexus is creating tools to detect, characterize, and isolate single cells of interest from complex heterogeneous samples.
Continue scrolling down to learn more...


Our flagship product enables isolation of target single cells in a viable and pure manner. The NX∙One has broad applicability both upstream and downstream of existing workflows.


Modes of Operation

1)  Standalone system for isolation and dispensing of individual single-cells or cells in bulk - detection of cells is based on size criteria or a single-marker of interest

2)  Upstream of genomic analyses (PCR, NGS, RNA-Seq, microarray), immunofluorescent imaging, proteomics tools, culture, or other single-cell processing

3)  Downstream of existing instrumentation such as FACS, MACS, or liquid biopsy systems for volume enrichment and/or single-cell isolation

Our proprietary technology suite, both independently developed and exclusively licensed from the University of California, comes together to form a single-use disposable microfluidic cartridge that detects, analyzes, and collects desired cells of interest. Because our technology is label-free, there is minimal sample preparation that is needed for testing, reducing hands-on time and labor costs.


Exclusive Licensees of the Regents of the University of California


Publications highlighting this exclusively licensed IP have received a number of awards:

  • 2014 - A proposal highlighting the core sensing module was selected as one of five winners internationally, and recognized as a Revolutionary Platform Technology for Advancing Life Sciences Research as part of the Innocentive Challenge. The Challenge was sponsored by the W. M. Keck Foundation, Gordon & Betty Moore Foundation, Kavli Foundation, Burroughs-Wellcome Trust, Templeton Foundation, and Research Corporation.

  • 2013 - A publication featuring the sensing technology was awarded by the Editors of Lab on a Chip to be selected for the themed category, “Lab on a Chip Top 10%,” for being of “exceptional significance for the miniturisation community” and demonstrating a “breakthrough in device technology [and] methodology”. Nodexus co-Founders Karthik Balakrishnan and Anand Kesavaraju are both authors on this paper.